94953 ⎘
Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
PROCESS FOR THE PREPARATION OF TAXANE DERIVATIVES
#2METHODS AND SYSTEM FOR STIMULATING ROOT EXUDATION IN PLANTS
#3PHENYL-SULFAMOYL-BENZOIC ACID DERIVATIVES AS ERAP1- MODULATORS
#4N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#5THERAPEUTIC AMINOINDANE COMPOUNDS AND COMPOSITIONS
#6AQUEOUS FORMULATIONS OF CYTOTOXIC TAXANES WITH CYCLODEXTRIN
#7LIPIDS FOR DELIVERY OF NUCLEIC ACID SEGMENTS
#8NAMPT MODULATORS
#9NANOPARTICLES COMPRISING DRUG DIMERS, AND USE THEREOF
#10COMPOSITIONS AND FORMULATIONS INCLUDING CABAZITAXEL AND HUMAN SERUM ALBUMIN
#11Curable composition, cured product, optical member, lens, and compound
#12MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE
#13Methods and system for stimulating root exudation in plants
#14Compositions and formulations including cabazitaxel and human serum albumin
#15Isocyanates, derivatives, and processes for producing the same
#169,10-Alpha,Alpha-OH-Taxane Analogs and Methods for Production Thereof
#17SSAO INHIBITORS AND USES THEREOF
#18MODIFIED CYTOTOXINS AND THEIR THERAPEUTIC USE
#19Type of taxane compound, preparation method and application thereof
#20Lipid-linked prodrugs
#21CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAME
#229,10-α,α-OH-taxane analogs and methods for production thereof
#23Acid-Labile Lipophilic Prodrugs of Cancer Chemotherapeutic Agents
#24Technology for the Preparation of Microparticles
#25Processes for producing beta-lactone and beta-lactone derivatives with heterogenous catalysts
#26Multi-arm polymeric prodrug conjugates of taxane-based compounds
#27Systems and processes for thermolysis of polylactones to produce organic acids
#28Water-soluble docetaxel anticancer drug compound and preparation method and use thereof
#29Method for analyzing related substances of a pharmaceutical composition containing a polymeric carrier
#30Modified cytotoxins and their therapeutic use
#31MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES
#32Third generation taxoids and methods of using same
#33Aromatic compounds and uses thereof
#34Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#359,10-α,α-OH-taxane analogs and methods for production thereof
#36Technology for the Preparation of Microparticles
#37DRUG COMPLEXES COMPRISING ALPHA-FETOPROTEIN
#38Crystalline forms of dimethoxy docetaxel and methods for preparing the same
#39Modified cytotoxins and their therapeutic use
#40C-glycoside derivative
#41Modified cytotoxins and their therapeutic use
#42Purification of taxanes
#43Water-soluble taxane derivatives and uses thereof
#44Carboxylic acid derivatives and use thereof in the preparation of prodrugs
#45Process for cabazitaxel
#46Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#47PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL
#489, 10-α, α-oh-taxane analogs and methods for production thereof
#49Carbocyclic sulfone RORγ modulators
#50CRYSTALLINE FORM OF CABAZITAXEL AND PROCESS FOR PREPARING THE SAME
#51Taxanes compounds, preparation method therefor, and uses thereof
#52CRYSTALLINE SOLVATE FORMS OF CABAZITAXEL
#53Crystalline anhydrous form of Cabazitaxel, process for the preparation and pharmaceutical compositions thereof
#54Multi-arm polymeric prodrug conjugates of taxane-based compounds
#55Synthesis of novel asymmetric bow-tie PAMAM dendrimer-based conjugates for tumor-targeting drug delivery
#56Purification of taxanes
#57Thermal extraction method and product
#58METHOD FOR PRODUCING (1S,4S,5S)-4-BROMO-6-OXABICYCLO[3.2.1]OCTAN-7-ONE
#59Dipicolylamine derivatives and their pharmaceutical uses
#60PROCESS FOR PREPARING AMORPHOUS CABAZITAXEL
#61Process for the preparation of cabazitaxel and its intermediates
#62Method for preparing cabazitaxel from 10-deacetylbaccatin III in high yield, and novel intermediate therefor
#63Chemiluminescent compositions, methods, assays and kits for oxidative enzymes
#64MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME
#65Crystal form of cabazitaxel and preparation method thereof
#66NOVEL CRYSTALLINE FOR W OF CABAZITAXEL AND METHOD FOR PREPARING IT
#679,10-α, α-OH-taxane analogs and methods for production thereof
#68THERAPEUTIC STRATEGY FOR TREATING AUTOIMMUNE AND DEGENERATIVE DISEASES
#69Taxane compounds, compositions and methods
#70Solid State Forms Of Cabazitaxel And Processes For Preparation Thereof
#71Technology for the Preparation of Microparticles
#72Solid state forms of cabazitaxel and processes for preparation thereof
#73Purification of taxanes
#74Sorbent comprising on its surface a cationic or protonizable aliphatic residue for the purification of organic molecules
#75Cabazitaxel, related compounds and methods of synthesis
#76Modified drugs for use in liposomal nanoparticles
#77CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAME
#78Crystalline form of cabazitaxel and process for preparing the same
#79Process for preparing amorphous cabazitaxel
#80Crytalline form of 13-[(N-tert-butoxycarbonyl)-2′-O-hexanoyl-3-phenylisoserinyl]-10-deacetylbaccatin III
#81Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#82Taxane compounds, compositions and methods
#83Antineoplastic hydrogels, and enzyme-instructed preparations thereof
#84Amorphous cabazitaxel
#85Beta-lactones as antibacterial agents
#86Method for manufacturing oxetane compound, method for manufacturing azolylmethylcyclopentanol compound, and intermediate compound
#87Solid forms of ortataxel
#88Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds
#89Process for the preparation cabazitaxel
#90Crystalline forms of cabazitaxel
#91Process for preparing docetaxel and its hydrate
#92Non-ring hydroxy substituted taxanes and methods for synthesizing the same
#93Solid state forms of cabazitaxel and processes for preparation thereof
#94DEUTERATED AND/OR FLUORINATED TAXANE DERIVATIVES
#95MULTI-ARM POLYMERIC PRODRUG CONJUGATES OF TAXANE-BASED COMPOUNDS
#96GLP-1 potentiators from hedychium coronarium and their applications
#97Paclitaxel trihydrates and methods of making thereof
#98Crystalline forms of cabazitaxel and process for preparation thereof
#99Crystalline forms of dimethoxy docetaxel and methods for preparing the same
#100Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate
#101Amorphous form of cabazitaxel and process for its preparation
#102PROCESS FOR MAKING AN INTERMEDIATE OF CABAZITAXEL
#103Crystalline forms of cabazitaxel
#104Method for preparing highly pure anhydrous crystalline docetaxel
#105Green Chemical Process to Produce Natural Products
#106Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents
#107Modified drugs for use in liposomal nanoparticles
#108Taxane compounds, compositions and methods
#109Process for preparing taxoids from baccatin derivatives using lewis acid catalyst
#110MULTIFUNCTIONAL LINKERS AND METHODS FOR THE USE THEREOF
#111Antineoplastic hydrogels, and enzyme-instructed preparations thereof
#112Technology for the Preparation of Microparticles
#113Chemiluminescent compositions, methods, assays and kits for oxidative enzymes
#1149, 10-α, α-OH-taxane analogs and methods for production thereof
#115SOLVATES OF DOCETAXEL
#116Method for preparing taxane derivatives
#117Bis(thio-hydrazide amide) salts for treatment of cancers
#118Auto magnetic metal salen complex compound
#119Taxane compounds, compositions and methods
#120PREPARATION OF DOCETAXEL
#121Prodrugs containing novel bio-cleavable linkers
#122Prodrugs containing novel bio-cleavable linkers
#123Prodrugs containing novel bio-cleavable linkers
#124Nitric Oxide Releasing Prodrugs of Therapeutic Agents
#125ANTITUMOUR COMPOSITIONS CONTAINING TAXANE DERIVATIVES
#126Compounds and processes that generate cyclopropenes and substituted cyclopropenes on demand
#127Beta-lactones as antibacterial agents
#128Hydrazide containing taxane conjugates
#129Modified drugs for use in liposomal nanoparticles
#130Crystalline forms of dimethoxy docetaxel and methods for preparing the same
#131Preparation of taxanes from 9-dihydro-13-acetylbaccation III
#132Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents
#133PROCESS FOR CONVERTING 9-DIHYDRO-13ACETYLBACCATIN III PACLITAXEL AND DOCETAXEL
#134Process for preparation of taxane derivatives
#135NEW METHODS FOR THE PREPARATION OF TAXANES USING CHIRAL AUXILIARIES
#136NEW METHODS FOR THE PREPARATION OF TAXANES USING CHIRAL AUXILIARIES
#137SOLID FORMS OF ORTATAXEL
#138CEPHALOMANNINE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#139Taxane delivery system
#140Poly(citric acid) functionalized carbon nanotube drug delivery system
#141Bis(thio-hydrazide amide) salts for treatment of cancers
#1429, 10-α,α-OH-taxane analogs and methods for production thereof
#143METHOD OF PREPARING TAXANE DERIVATIVES AND INTERMEDIATES USED THEREIN
#144Process for the preparation of docetaxel, its intermediates, and methods for preparation thereof
#145Paclitaxel enhancer compounds
#146PROCESSES FOR THE PRODUCTION OF POLYCYCLIC FUSED RING COMPOUNDS
#147DIRECT DISSOLUTION OF DOCETAXEL IN A SOLVENT IN POLYSORBATE 80
#148DOCETAXEL POLYMORPHS AND PROCESSES
#149Purification of taxanes
#150STABLE ANHYDROUS CRYSTALLINE DOCETAXEL AND METHOD FOR THE PREPARATION THEREOF
#151METHOD OF PREPARING DOCETAXEL AND INTERMEDIATES USED THEREIN
#152Semi-synthetic process for the preparation of taxane derivatives
#153C(10) ethyl ester and C(10) cyclopropyl ester substituted taxanes
#154CONVERGENT PROCESS FOR THE SYNTHESIS OF TAXANE DERIVATIVES.
#155C-10 carbamates of taxanes
#156Thermal extraction method and product
#157Process for the purification 10-deacetylbaccatine III from 10-deacetyl-2-debenzoyl-2-pentenoylbaccatine III
#158PROCESSES FOR PREPARATION OF TAXANES AND INTERMEDIATES THEREOF
#159Low pressure carbonylation of heterocycles
#160Bis(thio-hydrazide amide) salts for treatment of cancers
#161Crystalline forms of docetaxel and process for preparation thereof
#162Process for the isolation of paclitaxel
#163ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND
#164CONVERSION 9-DIHYDRO-13-ACETYLBACCATIN III TO 10-DEACETYLBACCATIN III
#165Novel Compounds and Methods for Forming Taxanes and Using the Same
#166PHARMACEUTICAL COMPOSITION CONTAINING TAXANE DERIVATIVE DESTINED FOR THE PREPARATION OF AN INFUSION SOLUTION, METHOD OF PREPARATION THEREOF AND USE THEREOF
#167Methods for the preparation of taxanes using chiral auxiliaries
#168Fluorotaxoids
#169Technology for the Preparation of Microparticles
#170DEUTERIUM-ENRICHED LAROTAXEL
#171DEUTERIUM-ENRICHED PACLITAXEL
#172Stable pharmaceutical compositions with docetaxel
#173Preparation of taxanes from 9-dihydro-13-acetylbaccatin III
#174Method for preparation of amorphous, anhydrous crystalline or hydrated crystalline docetaxel
#175Stationary phase and column using cucurbituril bonded silica gel, and separation method of taxol using the column
#176Process for the preparation of synthetic taxanes
#177Docetaxel Immunoassay
#178BIS (thio-hydrazide amide) salts for treatment of cancers
#179Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
#180Therapeutic Strategy for Treating Autoimmune and Degenerative Diseases
#181Semi-Synthetic Taxane Derivatives With Antitumor Activity
#182Process for the Separation of Paclitaxel and Cephalomannin
#183Paclitaxel enhancer compounds
#184Method for preparing paclitaxel
#185Semisynthesis process for the preparation of 10 deacetyl-N-debenzoyl-paclitaxel
#186Method for Preparing Docetaxel
#187Flourene Derivative
#188Medicament For Irritable Bowel Syndrome
#189Semisynthesis Process for the Preparation of 10-Deacytyl-N-Debenzoyl-Paclitaxel
#190FATTY AMINE DRUG CONJUGATES
#191Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
#192Drug conjugates
#193Crystalline forms of docetaxel and process for preparation thereof
#194FATTY ALCOHOL DRUG CONJUGATES
#195Anti-tuberculosis taxane compounds
#196Purification of taxanes and taxane mixtures using polyethyleneimine-bonded resins
#197Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxy-carbonyl]-5-oxazolidine carboxylic acids
#198Semi-synthetic conversion of paclitaxel to docetaxel
#199Methods and compositions for converting taxane amides to paclitaxel or other taxanes
#200Process for the preparation of concentrated, sterile injectable solutions containing docetaxel
#201Molecular transporters based on alditol or inositol and processes for the preparation thereof
#202Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel
#203Cytotoxic agents comprising taxanes and their therapeutic use
#204Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
#205Cytotoxic agents comprising new C-2 modified taxanes
#206C7 ESTER AND C10 HYDROXY SUBSTITUTED TAXANES
#207TAXANES HAVING C7 HYDROXY AND C10 HETEROSUBSTITUTED ACETATE SUBSTITUENTS
#208Binding molecules and methods of use thereof
#209Convergent Process for the Synthesis of Taxane Derivatives
#210Low pressure carbonylation of heterocycles
#211Intermediates for the hemisynthesis of taxanes and preparation processes therefor
#212Cytotoxic agents comprising taxanes and their therapeutic use
#213Cytotoxic agents comprising taxanes and their therapeutic use
#214Process for purification and recovery of paclitaxel compounds
#215Crystalline forms of docetaxel and processes for their preparation
#216Lipophilic di(anticancer drug) compounds, compositions, and related methods
#217Podophyllotoxin derivatives as igf-1r inhibitors
#218Method for separation and purification of 13-dehydroxybaccatin III and 10-deacetylpaclitaxel from taxans-containing materials
#219Taxane metabolites
#220Taxoid-fatty acid conjugates and pharmaceutical compositions thereof
#221Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
#222Semi-synthesis of taxane intermediates from a mixture of taxanes
#223Novel taxanes and methods related to use and preparation thereof
#224Semi-synthetic conversion of paclitaxel to docetaxel
#225Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel
#226One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
#227Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
#228Processes for the production of polycyclic fused ring compounds
#229Processes for the preparation of paclitaxel
#230Processes for the preparation of docetaxel
#231Cyclic fluorine compounds, polymerizable fluoromonomers, fluoropolymers, and resist materials containing the fluoropolymers and method for pattern formation
#232Stabilized formulation
#233Process for the preparation of docetaxel trihydrate
#234Docetaxel immunoassay
#235Docetaxel immunoassay
#236Prodrugs containing novel bio-cleavable linkers
#237Fluorinated monomers, fluorinated polymers having polycyclic groups with fused 4-membered heterocyclic rings, useful as photoresists, and processes for microlithography
#238Bis(thio-hydrazide amide) salts for treatment of cancers
#239Cytotoxic agents comprising taxanes and their therapeutic use
#240Taxane derivatives functionalized at the 14-position and a process for the preparation thereof
#241Paclitaxel enhancer compounds
#242Crystalline forms of 3'-tert-Butyl-3'-N-tert-butyloxycarbonyl-4-deacetyl-3'-dephenyl-3'-N-debenzoyl-4-O-methoxycarbonyl-paclitaxel
#243Taxanes having a C10 carbonate substituent
#244Methods and compositions for enhancing transport across biological membranes
#245Cytotoxic agents comprising taxanes and their therapeutic use
#246Semisynthesis process for the preparation of 10-deacetyl-N-debenzoyl-paclitaxel
#247Prodrugs containing novel bio-cleavable linkers
#248Method and compositions for preparing a compound using a benzoylating agent essentially free of ring chlorination
#249Methods for obtaining paclitaxel from taxus plants
#250Semi-synthetic conversion of paclitaxel to docetaxel
#251One pot synthesis of taxane derivatives and their conversion to paclitaxel and docetaxel
#252Process for C7 silylation of hydroxy substituted taxanes and intermediates thereof
#253Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
#254Cytotoxic agents comprising taxanes and their therapeutic use
#255Facile method for synthesizing baccatin III compounds
#256Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
#257Methods of treating cancer using C-4 carbonate taxanes
#258Semi-synthesis of taxane intermediates from a mixture of taxanes
#259Conversion of taxane molecules
#260Drug conjugates
#261Antitumour compositions containing taxane derivatives
#262Intermediates for the hemisynthesis of taxanes and preparation processes therefor
#263C7 lactyloxy-substituted taxanes
#264Molecular conjugates for use in treatment of cancer
#265Semi-synthesis of taxane intermediates and aziridine analogues and their conversion to paclitaxel and docetaxel
#266C10 carbamoyloxy substituted taxane compositions
#267Selective acylation of secondary hydroxyl groups
#268Method for purification of paclitaxel from paclitaxel-containing materials
#2699,10-α,α-OH-taxane analogs and methods for production thereof
#270C10 heterosubstituted acetate taxane compositions
#271Taxanes having a C7 heterosubstituted acetate substituent
#272Baccatin III derivatives
#273β-Lactams, methods for the preparation of taxanes, and sidechain-bearing taxanes
#274Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III
#275Cytotoxic agents containing novel potent taxanes and their therapeutic use
#276Acetone solvate of dimethoxy docetaxel and its process of preparation
#277Process for preparing 4-alkyl- or 4-aryl-oxycarbonyl paclitaxel analogs and novel intermediates
#278Semi-synthetic process for the preparation of N-debenzoylpaclitaxel
#279Cytotoxic agents containing novel potent taxanes and their therapeutic use
#280Process for the preparation of the 14β-hydroxy-baccatin III-1,14-carbonate
#281C7 carbamoyloxy substituted taxane compositions
#282Stabilized formulation
#283Taxol enhancer compounds
#284Processes for producing beta-lactone with heterogenous catalysts